Arcus Biosciences Inc (RCUS)
Gross profit margin
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross profit (ttm) | US$ in thousands | -5,000 | -19 | 5,568 | 5,491 | 5,065 | 331,027 | 316,558 | 315,981 | 323,958 | 3,502 | 63,737 | 53,709 | 47,058 | 47,321 | -12,840 | -8,119 | -6,191 | -14,379 | -6,857 | -4,096 |
| Revenue (ttm) | US$ in thousands | 117,000 | 119,355 | 121,236 | 118,995 | 112,000 | 433,144 | 408,724 | 399,137 | 398,304 | 53,292 | 108,361 | 92,939 | 77,517 | 77,780 | 15,000 | 15,000 | 15,000 | 6,812 | 9,353 | 8,853 |
| Gross profit margin | -4.27% | -0.02% | 4.59% | 4.61% | 4.52% | 76.42% | 77.45% | 79.17% | 81.33% | 6.57% | 58.82% | 57.79% | 60.71% | 60.84% | -85.60% | -54.13% | -41.27% | -211.08% | -73.31% | -46.27% |
December 31, 2023 calculation
Gross profit margin = Gross profit (ttm) ÷ Revenue (ttm)
= $-5,000K ÷ $117,000K
= -4.27%
Arcus Biosciences Inc has consistently reported a gross profit margin of 100% across all quarters from Q1 2022 to Q4 2023. This indicates that the company effectively manages its production costs and pricing strategies, resulting in a high level of gross profit compared to its revenue. A gross profit margin of 100% suggests that Arcus Biosciences Inc is efficiently generating revenue from its core business activities while effectively controlling its cost of goods sold. This strong and consistent performance in gross profit margin reflects positively on the company's operational efficiency and pricing strategy.
Peer comparison
Dec 31, 2023